Descriptor English: | Medigoxin | ||||||
Descriptor Spanish: |
Medigoxina
| ||||||
Descriptor Portuguese: | Medigoxina | ||||||
Descriptor French: | Médigoxine | ||||||
Entry term(s): |
4''' O Methyldigoxin 4'''-O-Methyldigoxin Bemecor Lanirapid Lanitop Medixin Methyldigoxin Metildigoxin beta Methyldigoxin beta-Methyldigoxin |
||||||
Tree number(s): |
D04.210.500.155.580.130.500.436.500 D04.210.500.155.580.130.688.500 D09.408.180.261.436.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D008520 | ||||||
Scope note: | A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE). |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Arrhythmia Agents Cardiotonic Agents Enzyme Inhibitors |
||||||
Registry Number: | I7GG1YUC5V | ||||||
CAS Type 1 Name: | Card-20(22)-enolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)- | ||||||
Previous Indexing: |
Digoxin (1966-1978) |
||||||
Public MeSH Note: | 91; was see under DIGOXIN 1979-90 |
||||||
History Note: | 91(79); was see under DIGOXIN 1979-90 |
||||||
DeCS ID: | 8687 | ||||||
Unique ID: | D008520 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1991/01/01 | ||||||
Date of Entry: | 1978/03/20 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Medigoxin
- Preferred
Medixin
- Narrower
Bemecor
- Narrower
Lanitop
- Narrower
Methyldigoxin
- Broader
Lanirapid
- Narrower
Concept UI |
M0013272 |
Scope note | A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE). |
Preferred term | Medigoxin |
Entry term(s) |
4''' O Methyldigoxin 4'''-O-Methyldigoxin Metildigoxin beta Methyldigoxin beta-Methyldigoxin |
Concept UI |
M0351184 |
Preferred term | Medixin |
Concept UI |
M0351159 |
Preferred term | Bemecor |
Concept UI |
M0351183 |
Preferred term | Lanitop |
Concept UI |
M0013273 |
Preferred term | Methyldigoxin |
Concept UI |
M0474839 |
Preferred term | Lanirapid |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey